<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
69761-222-30
</NDCCode>
<PackageDescription>
30 PELLET in 1 PACKAGE (69761-222-30)
</PackageDescription>
<NDC11Code>
69761-0222-30
</NDC11Code>
<ProductNDC>
69761-222
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Testosterone / Anastrozole
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Testosterone / Anastrozole
</NonProprietaryName>
<DosageFormName>
PELLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20171114
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Qualgen LLC
</LabelerName>
<SubstanceName>
ANASTROZOLE; TESTOSTERONE
</SubstanceName>
<StrengthNumber>
20; 200
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA],Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS]
</Pharm_Classes>
<DEASchedule>
CIII
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2021-10-06
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20171114
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>